JPS6316394B2 - - Google Patents

Info

Publication number
JPS6316394B2
JPS6316394B2 JP19262781A JP19262781A JPS6316394B2 JP S6316394 B2 JPS6316394 B2 JP S6316394B2 JP 19262781 A JP19262781 A JP 19262781A JP 19262781 A JP19262781 A JP 19262781A JP S6316394 B2 JPS6316394 B2 JP S6316394B2
Authority
JP
Japan
Prior art keywords
chloroform
yield
group
dissolved
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP19262781A
Other languages
Japanese (ja)
Other versions
JPS5896096A (en
Inventor
Hamao Umezawa
Sumio Umezawa
Osamu Tsucha
Tomio Takeuchi
Akihiro Tanaka
Hidenori Iwamoto
Shuichi Sakamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Priority to JP19262781A priority Critical patent/JPS5896096A/en
Priority to AU85524/82A priority patent/AU551142B2/en
Priority to US06/395,463 priority patent/US4477443A/en
Priority to ES513827A priority patent/ES513827A0/en
Priority to DE8282303622T priority patent/DE3269164D1/en
Priority to EP84201085A priority patent/EP0132895A1/en
Priority to EP84201086A priority patent/EP0134054A1/en
Priority to EP82303622A priority patent/EP0070170B1/en
Priority to AT82303622T priority patent/ATE18055T1/en
Priority to ES520906A priority patent/ES520906A0/en
Publication of JPS5896096A publication Critical patent/JPS5896096A/en
Priority to SU833622804A priority patent/SU1209032A3/en
Publication of JPS6316394B2 publication Critical patent/JPS6316394B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は新規なマイカミノシル タイロノライ
ド誘導体、さらに詳しくは、一般式 〔式中、Rは水酸基、ハロゲン原子、または式
The present invention provides novel mycaminosyl tylonolide derivatives, more specifically, the general formula [In the formula, R is a hydroxyl group, a halogen atom, or a formula

【式】(式中、R1およびR2は同一また は異なつて水素原子、低級アルキル基、アリール
基、アラルキル基または炭素数5〜10個のシクロ
アルキル基を表わす。またR1とR2は互いに結合
して炭素数3〜20個のアルキレン基を形成しても
よい。)で示される基を表わす。〕 で示される19−デカルボニル−4′−デオキシマイ
カミノシル タイロノライド誘導体に関する。 前記における低級アルキル基は炭素数1〜6個
の直鎖状または分枝状のアルキル基を意味し、た
とえばメチル基、エチル基、イソプロピル基、ブ
チル基、ヘキシル基等である。またハロゲン原子
の例としては、塩素原子、ヨウ素原子、臭素原子
等が、アリール基の例としては、フエニル基、ナ
フチル基等が、アラルキル基の例としてはベンジ
ル基、フエネチル基、フエニルプロピル基等が挙
げられる。 本発明化合物はすぐれた抗菌活性、特にグラム
陰性菌に対して強い抗菌力を示し、抗菌剤として
有用な化合物である。 本発明者等はマクロライド系化合物について鋭
意研究した結果、マイカミノシル タイロノライ
ドの4′位を脱オキシ化し、19位を脱カルボニル化
した化合物およびさらに22位にハロゲン原子また
はアミノ系置換基を付けた化合物がすぐれた抗菌
活性を有することを見い出し本発明を完成するに
至つた。 本発明化合物は次の方法によつて製造すること
ができる。 第1製法 一般式〔〕においてRが水酸基である化合物
は構造式 で示される4′−デオキシ マイカミノシル タイ
ロノライドにクロロトリス(トリフエニルホスフ
イン)ロジウム〔C6H53P〕3RhClを作用させて
製造することができる。 この反応はベンゼン、トルエン、キシレン等の
有機溶媒中で、室温または加温下に、好ましくは
窒素気流下で行うのが好ましい。 第2製法 一般式〔〕においてRがハロゲン原子である
化合物は第1製法で得られる構造式 で示される19−デカルボニル−4′−デオキシマイ
カミノシル タイロノライドをハロゲン化するこ
とによつて製造することができる。 このハロゲン化は塩素、臭素、ヨウ素、四塩化
炭素、四臭化炭素、四ヨウ化炭素等のハロゲン化
剤を用いて、室温または冷却下、好ましくは氷冷
下で行うのが好ましい。トリフエニルホスフイン
および必要によりピリジンなどの塩基の添加は反
応を促進する上で好ましい。これらの添加剤の中
には溶媒を兼ねることができるものがあるが、必
要により、ピリジン、アセトニトリル、テトラヒ
ドロフラン、ジオキサンなどの溶媒を単独または
適宜混合して使用してもよい。 第3製法 一般式〔〕においてRが式
[Formula] (wherein R 1 and R 2 are the same or different and represent a hydrogen atom, a lower alkyl group, an aryl group, an aralkyl group, or a cycloalkyl group having 5 to 10 carbon atoms. may be bonded to each other to form an alkylene group having 3 to 20 carbon atoms. ] The present invention relates to a 19-decarbonyl-4'-deoxymycaminosyl tylonolide derivative represented by the following. The lower alkyl group mentioned above means a linear or branched alkyl group having 1 to 6 carbon atoms, such as a methyl group, an ethyl group, an isopropyl group, a butyl group, a hexyl group, and the like. Examples of halogen atoms include chlorine, iodine, and bromine; examples of aryl groups include phenyl and naphthyl; and examples of aralkyl include benzyl, phenethyl, and phenylpropyl. etc. The compound of the present invention exhibits excellent antibacterial activity, particularly strong antibacterial activity against Gram-negative bacteria, and is a useful compound as an antibacterial agent. As a result of intensive research on macrolide compounds, the present inventors have developed a compound in which the 4'-position of mycaminosyl tylonolide is deoxylated and the 19-position is decarbonylated, and a compound in which a halogen atom or an amino substituent is added to the 22-position. The present invention was completed based on the discovery that the compound has excellent antibacterial activity. The compound of the present invention can be produced by the following method. 1st Production Method A compound in which R is a hydroxyl group in the general formula [] has the structural formula It can be produced by reacting 4'-deoxy mycaminosyl tylonolide represented by chlorotris(triphenylphosphine)rhodium [C 6 H 5 ) 3 P] 3 RhCl. This reaction is preferably carried out in an organic solvent such as benzene, toluene, or xylene at room temperature or with heating, preferably under a nitrogen stream. Second Production Method A compound in which R is a halogen atom in the general formula [] has the structural formula obtained by the first production method. It can be produced by halogenating 19-decarbonyl-4'-deoxymycaminosyl tylonolide represented by: This halogenation is preferably carried out at room temperature or under cooling, preferably under ice cooling, using a halogenating agent such as chlorine, bromine, iodine, carbon tetrachloride, carbon tetrabromide, carbon tetraiodide, or the like. Addition of triphenylphosphine and, if necessary, a base such as pyridine is preferred for promoting the reaction. Some of these additives can also serve as a solvent, and if necessary, solvents such as pyridine, acetonitrile, tetrahydrofuran, and dioxane may be used alone or in an appropriate mixture. Third manufacturing method In the general formula [], R is the formula

【式】で 示される基である化合物は第2製法で得られる構
造式 (式中、Xはハロゲン原子を表わす。) で示される19−デカルボニル−22,4′−ジデオキ
シ−22−ハロゲノ マイカミノシル タイロノラ
イドと一般式 で示されるアミンとを反応させることによつて製
造することができる。 この反応はテトラヒドロフラン、アセトニトリ
ル、ジオキサン、ジメチルホルムアミド、ジメチ
ルスルホキシド等の有機溶媒中で、室温または加
温下に行うのが好ましい。 次に本発明を参考例(出発物質の製造)および
実施例によつてさらに詳細に説明する。 参考例 1 (a) マイカミノシル タイロノライド825mgを8.3
mlの無水エタノールに溶かし、氷冷下で撹拌し
ながら、無水p−トルエンスルホン酸356mgを
加え、室温に戻した後、20分間反応させた。反
応液を再度氷冷し、トリエチルアミン0.3mlを
加えた後、減圧濃縮した。残留物を41mlのクロ
ロホルムに溶かし、10mlの飽和炭酸水素ナトリ
ウム水溶液、飽和塩化ナトリウム水溶液および
水で各1回洗浄し、クロロホルム層を無水硫酸
ナトリウムで乾燥後、減圧濃縮した。残留物を
40gのシリカゲルカラム上溶媒系クロロホルム
−メタノール(7:1)にてクロマト処理を行
い、マイカミノシル タイロノライド ジエチ
ルアセタールを得た。収量852mg(収率92%) (b) 上記(a)の生成物510mgを2.6mlのアセトニトリ
ルに溶かし、室温で撹拌しながら無水酢酸0.16
mlを加え、30分間反応させた。反応液を濃縮
し、トルエンでよく共沸し、過剰の無水酢酸お
よび酢酸を除去した後、50mlのクロロホルムに
溶かし、25mlの飽和炭酸水素ナトリウム水溶液
および水で各1回洗浄し、無水硫酸ナトリウム
で乾燥後、減圧濃縮して、2′,4′−ジ−O−ア
セチル マイカミノシル タイロノライド ジ
エチルアセタールを得た(定量的)。 (c) 上記(b)の生成物574mgを無水塩化メチレン
11.5mlに溶かし、氷冷下撹拌しながら、ジイソ
プロピルエチルアミン590mgを加えた後、クロ
ロメチルメチルエーテル367mgを加え、室温に
戻し、1日反応させた。反応液を29mlの飽和炭
酸水素ナトリウム水溶液中に注加し、クロロホ
ルム10mlで反応容器を洗いながら、その中に加
え、抽出した。さらに10mlのクロロホルムで2
回抽出をくり返し、クロロホルム層を合わせ、
15mlの飽和塩化ナトリウム水溶液および水で各
1回洗浄し、無水硫酸ナトリウムで乾燥後、減
圧濃縮して、3,23−ジ−O−メトキシメチル
−2′,4′−ジ−O−アセチル マイカミノシル
タイロノライド ジエチルアセタールを得た
(定量的)。 (d) 上記(c)の生成物641mgを30mlのメタノールに
溶解後、50℃で一夜反応させると、2′,4′位の
アセチル基が脱離され、3,23−ジ−O−メト
キシメチル マイカミノシル タイロノライド
ジエチルアセタールが得られた。収量509mg
(収率88%)。 (e) 前記(d)の生成物489mgを9.8mlの無水ピリジン
に溶解後、−40℃で撹拌しながら、ベンジルス
ルホニルクロリド185mgをゆつくり加え(約5
分間)、2時間反応させた。次いで−40℃のま
ま水0.02mlを加え、室温で30分間反応させ、過
剰のベンジルスルホニルクロライドを分解し、
減圧濃縮後、トルエンでよくピリジンを共沸し
た。反応液を25mlのクロロホルムに溶かし、10
mlの飽和炭酸水素ナトリウム水溶液、飽和塩化
ナトリウム水溶液および水で各1回洗浄し、無
水硫酸ナトリウムで乾燥後、減圧濃縮して、
3,23−ジ−O−メトキシメチル−4′−O−ベ
ンジルスルホニル マイカミノシル タイロノ
ライド ジエチルアセタールを得た。この物質
は不安定であるのでこのまま次の反応を行つ
た。収率約80% (f) 上記(e)の生成物588mgを12mlの無水メチルエ
チルケトンに溶かし、ヨウ化ナトリウム145mg
を加え、密栓し、80℃で20分間反応させた。反
応終了後、析出した固体をグラスフイルターで
過し、アセトンで固体を数回洗浄した後、減
圧濃縮した。残留物にクロロホルム20mlを加え
ると、再度沈澱が生じたのでこれもグラスフイ
ルターで過し、固体をクロロホルムで数回洗
浄後、クロロホルム層を8mlの飽和炭酸水素ナ
トリウム水溶液、0.1Mチオ硫酸ナトリウム水
溶液および水で各1回洗浄し、無水硫酸ナトリ
ウムで乾燥後、減圧濃縮した。残留物を25gの
シリカゲルカラム上溶媒系シクロヘキサン−ア
セトン(7:3)にてクロマト処理を行い、
3,23−ジ−O−メトキシメチル−4′−デオキ
シ−4′−ヨード マイカミノシル タイロノラ
イド ジエチルアセタノールを得た。収量452
mg (g) 上記(f)の生成物452mgを9mlの無水ベンゼン
に溶かし、水素化トリn−ブチルスズ445mg、
次いで反応開始剤であるα,α′−アゾビスイソ
ブチロニトリル8.2mgを加え、窒素気流下、密
栓し、80℃で2時間反応させた。反応液を減圧
濃縮し、40gのシリカゲルカラム上溶媒系シク
ロヘキサン−アセトン(4:1)で展開し、ト
リn−ブチルスズ化合物を溶出(250ml流す)
した後、系をクロロホルム−メタノール(9:
1)に変換し、クロマト処理を行い、3,23−
ジ−O−メトキシメチル−4′−デオキシ マイ
カミノシル タイロノライド ジエチルアセタ
ールを得た。収量311mg(収率82%) (h) 上記(g)の生成物45.5mgを0.23mlのジオキサン
に溶かし、10%トリフルオロ酢酸水溶液2.3ml
を加え、室温で2日間反応を行つた。次いで炭
酸水素ナトリウム301mgをゆつくり加えて中和
し、1mlのクロロホルムで3回抽出した。クロ
ロホルム層を合わせ、1mlの飽和塩化ナトリウ
ム水溶液および水で各1回洗浄し、無水硫酸ナ
トリウムで乾燥後、減圧濃縮した。4gのシリ
カゲルを溶媒系クロロホルム−メタノール−濃
アンモニア水(30:1:0.1)にて充填したカ
ラム上、同じ系で残留物を入れた後、系をクロ
ロホルム−メタノール−濃アンモニア水(8:
1:0.1)に変換しクロマト処理を行い、4′−
デオキシ マイカミノシル タイロノライドを
得た。収量26.0mg(収率73%) 理化学的性状
The compound that is a group represented by [Formula] has the structural formula obtained by the second production method. (In the formula, X represents a halogen atom.) 19-decarbonyl-22,4'-dideoxy-22-halogenomycaminosyl tylonolide and the general formula It can be produced by reacting with the amine shown below. This reaction is preferably carried out in an organic solvent such as tetrahydrofuran, acetonitrile, dioxane, dimethylformamide, dimethyl sulfoxide, etc. at room temperature or under heating. Next, the present invention will be explained in more detail by reference examples (preparation of starting materials) and examples. Reference example 1 (a) Mycaminocil tylonolide 825mg 8.3
ml of anhydrous ethanol, and while stirring under ice cooling, 356 mg of anhydrous p-toluenesulfonic acid was added, and after returning to room temperature, the mixture was reacted for 20 minutes. The reaction solution was ice-cooled again, 0.3 ml of triethylamine was added, and then concentrated under reduced pressure. The residue was dissolved in 41 ml of chloroform and washed once each with 10 ml of a saturated aqueous sodium hydrogen carbonate solution, a saturated aqueous sodium chloride solution, and water, and the chloroform layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. residue
Chromatography was performed on a 40 g silica gel column using a solvent system of chloroform-methanol (7:1) to obtain mycaminosyl tylonolide diethyl acetal. Yield: 852 mg (yield: 92%) (b) Dissolve 510 mg of the product from (a) above in 2.6 ml of acetonitrile, and add 0.16 mg of acetic anhydride with stirring at room temperature.
ml was added and allowed to react for 30 minutes. The reaction solution was concentrated and well azeotroped with toluene to remove excess acetic anhydride and acetic acid, then dissolved in 50 ml of chloroform, washed once each with 25 ml of saturated aqueous sodium bicarbonate solution and water, and dissolved with anhydrous sodium sulfate. After drying, it was concentrated under reduced pressure to obtain 2',4'-di-O-acetyl mycaminosyl tylonolide diethyl acetal (quantitative). (c) 574 mg of the product from (b) above was dissolved in anhydrous methylene chloride.
The mixture was dissolved in 11.5 ml, and while stirring under ice cooling, 590 mg of diisopropylethylamine was added, and then 367 mg of chloromethyl methyl ether was added, the temperature was returned to room temperature, and the reaction was allowed to proceed for 1 day. The reaction solution was poured into 29 ml of a saturated aqueous sodium hydrogen carbonate solution, and while washing the reaction vessel with 10 ml of chloroform, the mixture was added thereto and extracted. Add another 10 ml of chloroform.
Repeat the extraction twice, combine the chloroform layers,
Wash once each with 15 ml of saturated aqueous sodium chloride solution and water, dry over anhydrous sodium sulfate, and concentrate under reduced pressure to obtain 3,23-di-O-methoxymethyl-2',4'-di-O-acetyl mycaminocil. Tyronolide diethyl acetal was obtained (quantitative). (d) When 641 mg of the product from (c) above was dissolved in 30 ml of methanol and reacted overnight at 50°C, the acetyl groups at the 2' and 4' positions were eliminated and the 3,23-di-O-methoxy Methyl mycaminosyl tylonolide diethyl acetal was obtained. Yield 509mg
(Yield 88%). (e) After dissolving 489 mg of the product in (d) above in 9.8 ml of anhydrous pyridine, 185 mg of benzylsulfonyl chloride was slowly added while stirring at -40°C (approx.
minutes) and reacted for 2 hours. Next, 0.02 ml of water was added at -40°C, and the mixture was allowed to react at room temperature for 30 minutes to decompose excess benzylsulfonyl chloride.
After concentration under reduced pressure, pyridine was azeotroped well with toluene. Dissolve the reaction solution in 25 ml of chloroform and dilute for 10
Wash once each with 1 ml of saturated aqueous sodium hydrogen carbonate solution, saturated aqueous sodium chloride solution, and water, dry over anhydrous sodium sulfate, and concentrate under reduced pressure.
3,23-di-O-methoxymethyl-4'-O-benzylsulfonyl mycaminosyl tylonolide diethylacetal was obtained. Since this substance was unstable, the next reaction was carried out as it was. Yield approximately 80% (f) Dissolve 588 mg of the product from (e) above in 12 ml of anhydrous methyl ethyl ketone and add 145 mg of sodium iodide.
was added, the tube was sealed tightly, and the mixture was allowed to react at 80°C for 20 minutes. After the reaction was completed, the precipitated solid was filtered through a glass filter, washed several times with acetone, and then concentrated under reduced pressure. When 20 ml of chloroform was added to the residue, a precipitate formed again, so this too was filtered through a glass filter. After washing the solid several times with chloroform, the chloroform layer was mixed with 8 ml of saturated aqueous sodium bicarbonate solution, 0.1 M aqueous sodium thiosulfate solution and The mixture was washed once with water, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The residue was chromatographed on a 25 g silica gel column using a solvent system of cyclohexane-acetone (7:3).
3,23-di-O-methoxymethyl-4'-deoxy-4'-iodo mycaminosyl tylonolide diethylacetanol was obtained. Yield 452
mg (g) 452 mg of the product from (f) above was dissolved in 9 ml of anhydrous benzene, 445 mg of tri-n-butyltin hydride,
Next, 8.2 mg of α,α'-azobisisobutyronitrile as a reaction initiator was added, the mixture was tightly stoppered under a nitrogen stream, and the mixture was allowed to react at 80°C for 2 hours. The reaction solution was concentrated under reduced pressure, developed on a 40 g silica gel column with a solvent system of cyclohexane-acetone (4:1), and the tri-n-butyltin compound was eluted (flowing 250 ml).
After that, the system was diluted with chloroform-methanol (9:
Convert to 1), perform chromatography, and obtain 3,23-
Di-O-methoxymethyl-4'-deoxy mycaminosyl tylonolide diethyl acetal was obtained. Yield: 311 mg (yield: 82%) (h) Dissolve 45.5 mg of the product from (g) above in 0.23 ml of dioxane, and add 2.3 ml of 10% trifluoroacetic acid aqueous solution.
was added, and the reaction was carried out at room temperature for 2 days. Next, 301 mg of sodium hydrogen carbonate was slowly added to neutralize the mixture, and the mixture was extracted three times with 1 ml of chloroform. The chloroform layers were combined, washed once each with 1 ml of saturated aqueous sodium chloride solution and once with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. After putting the residue in the same system on a column packed with 4 g of silica gel in a solvent system of chloroform-methanol-concentrated aqueous ammonia (30:1:0.1), the system was packed with chloroform-methanol-concentrated aqueous ammonia (8:1).
1:0.1), chromatography, and 4'-
Deoxy mycaminosyl tylonolide was obtained. Yield 26.0mg (yield 73%) Physical and chemical properties

【表】【table】

【表】 (ii) 赤外線吸収スペクトル(KBr) WN(cm-1) 2960 −CH3 2930 −CH2− 1730 −COO− 1680 >C=O 1590 −C=C−C=C− (iii) 無色無定形固体(アセトン−n−ヘキサンよ
り精製) (iv) 元素分析値(C31N51NO9として) C(%) H(%) N(%) 理論値 64.00 8.84 2.41 実験値 63.72 8.81 2.21 (v) 〔α〕25 D−12(c1.2、CHCl)3 (vi) 紫外線吸収スペクトルλMeOH nax282.5(ε=
21000) (vii) Rf0.39 ワコーゲルB−5(商品名) クロロホルム−メタノール(6:1) 実施例 1 4′−デオキシ マイカミノシル タイロノライ
ド344mgを8.6mlの無水ベンゼンに溶かし、窒素気
流中、クロロトリス(トリフエニルホスフイン)
ロジウムを懸濁させ、80℃で12時間撹拌しながら
加温した。反応液を過し、液1N塩酸9mlで
3回抽出し、さらに水層を10%水酸化ナトリウム
水溶液で塩基性にして、10mlのクロロホルムで3
回抽出した。クロロホルム層を合わせ、10mlの飽
和硫酸ナトリウム水溶液で3回洗浄し、無水硫酸
ナトリウムで乾燥後、溶媒を留去した。残留物を
溶媒系クロロホルム−メタノール(10:1)を用
いてシリカゲルカラムで精製し、19−デカルボニ
ル−4′−デオキシ マイカミノシル タイロノラ
イドを得た。収量166.1mg(収率51%) アセトン−n−ヘキサンより再結晶 理化学的性状
[Table] (ii) Infrared absorption spectrum (KBr) WN (cm -1 ) 2960 -CH 3 2930 -CH 2 - 1730 -COO- 1680 >C=O 1590 -C=C-C=C- (iii) Colorless Amorphous solid (purified from acetone-n-hexane) (iv) Elemental analysis values (as C 31 N 51 NO 9 ) C (%) H (%) N (%) Theoretical value 64.00 8.84 2.41 Experimental value 63.72 8.81 2.21 ( v) [α] 25 D −12 (c1.2, CHCl) 3 (vi) Ultraviolet absorption spectrum λ MeOH nax 282.5 (ε=
21000) (vii) Rf0.39 Wakogel B-5 (trade name) Chloroform-methanol (6:1) Example 1 Dissolve 344 mg of 4'-deoxy mycaminosyl tylonolide in 8.6 ml of anhydrous benzene and add chlorotris (triphenylphosphine) in a nitrogen stream.
The rhodium was suspended and heated at 80° C. with stirring for 12 hours. The reaction solution was filtered and extracted three times with 9 ml of 1N hydrochloric acid, and the aqueous layer was made basic with 10% aqueous sodium hydroxide solution and extracted with 10 ml of chloroform three times.
Extracted twice. The chloroform layers were combined, washed three times with 10 ml of saturated aqueous sodium sulfate solution, dried over anhydrous sodium sulfate, and then the solvent was distilled off. The residue was purified on a silica gel column using a solvent system of chloroform-methanol (10:1) to obtain 19-decarbonyl-4'-deoxy mycaminosyl tylonolide. Yield 166.1 mg (yield 51%) Recrystallized from acetone-n-hexane Physical and chemical properties

【表】 (ii) 赤外線吸収スペクトル(KBr) WN(cm-1) 帰 属 2970 −CH3 2940 −CH2− 1700 −COO− 1675 >C=O 1590 −C=C−C=C− (iii) 無色プリズム晶(アセトン−n−ヘキサンよ
り再結晶) (iv) 融点181−183℃ (v) 元素分析値(C30H51NO8・H2Oとして) C(%) H(%) N(%) 計算値 63.02 9.34 2.45 実験値 62.95 9.14 2.34 (vi) 〔α〕25 D+35゜(c1.0、CHCl3) (vii) 紫外線吸収スペクトルλMeOH nax282nm(ε=
23000) 実施例 2 実施例1で得られた19−デカルボニル−4′−デ
オキシ マイカミノシル タイロノライド88.7mg
を無水ピリジン4.4mlに溶かし、トリフエニルホ
スフイン92.2mgを加え、氷冷下に撹拌しながら四
ヨウ化炭素91.3mgを加え、氷冷下90分間撹拌し
た。反応液にメタノール0.06mlを加えて反応を停
止した後、溶媒を留去した。(トルエンでピリジ
ンを数回共沸して除去した。)残留物をクロロホ
ルムに溶かし、不溶物を去した後、クロロホル
ム層を飽和炭酸水素ナトリウム水溶液、0.1Mチ
オ硫酸ナトリウム水溶液および飽和硫酸ナトリウ
ム水溶液で各1回洗浄し、無水硫酸ナトリウムで
乾燥後、溶媒を留去した。残留物を溶媒系クロロ
ホルム−メタノールを用いてシリカゲルカラムで
精製し、19−デカルボニル−22,4′−デオキシ−
22−ヨード マイカミノシル タイロノライドを
得た。収量94.4mg(収率89%) アセトン−n−ヘキサンより再結晶 理化学的性状
[Table] (ii) Infrared absorption spectrum (KBr) WN (cm -1 ) Attribution 2970 −CH 3 2940 −CH 2 − 1700 −COO− 1675 >C=O 1590 −C=C−C=C− (iii ) Colorless prismatic crystal (recrystallized from acetone-n-hexane) (iv) Melting point 181-183℃ (v) Elemental analysis value (as C 30 H 51 NO 8・H 2 O) C (%) H (%) N (%) Calculated value 63.02 9.34 2.45 Experimental value 62.95 9.14 2.34 (vi) [α] 25 D +35° (c1.0, CHCl 3 ) (vii) Ultraviolet absorption spectrum λ MeOH nax 282 nm (ε=
23000) Example 2 88.7 mg of 19-decarbonyl-4'-deoxy mycaminosyl tylonolide obtained in Example 1
was dissolved in 4.4 ml of anhydrous pyridine, 92.2 mg of triphenylphosphine was added, and 91.3 mg of carbon tetraiodide was added while stirring under ice cooling, followed by stirring for 90 minutes under ice cooling. After terminating the reaction by adding 0.06 ml of methanol to the reaction solution, the solvent was distilled off. (Pyridine was removed by azeotropic distillation several times with toluene.) The residue was dissolved in chloroform, and after removing insoluble matter, the chloroform layer was dissolved in a saturated aqueous sodium bicarbonate solution, a 0.1M aqueous sodium thiosulfate solution, and a saturated aqueous sodium sulfate solution. After washing once each and drying over anhydrous sodium sulfate, the solvent was distilled off. The residue was purified on a silica gel column using the solvent system chloroform-methanol to obtain 19-decarbonyl-22,4'-deoxy-
22-Iodomycaminosyl tylonolide was obtained. Yield 94.4 mg (yield 89%) Recrystallized from acetone-n-hexane Physical and chemical properties

【表】 (ii) 赤外線吸収スペクトル(KBr) WN(cm-1) 帰 属 2970 −CH3 2940 −CH2− 1710 −COO− 1680 >C=O 1590 −C=C−C=C− (iii) 無色針状晶(アセトン−n−ヘキサンより再
結晶) (iv) 融点209−210℃ (v) 元素分析値(C30H50NO7Iとして) C(%) H(%) N(%) I(%) 計算値 54.30 7.59 2.11 19.12 実験値 54.58 7.51 2.31 19.25 (vi) 〔α〕25 D+97゜(c1.0、CHCl3) (vii) 紫外線吸収スペクトルλMeOH nax282nm(ε=
24000) 実施例 3 実施例2で得られた19−デカルボニル−22,
4′−ジデオキシ−22−ヨード マイカミノシル
タイロノライド63.6mgを1.3mlの無水アセトニト
リルに溶かし、約4Mジメチルアミン−アセトニ
トリル溶液を0.24ml加えた。密栓を施し、80℃で
30分間加温した後、さらに0.24mlの前記溶液を加
え、30分間加温した。溶媒を留去した後、残留物
をクロロホルムに溶かし、クロロホルム層を飽和
炭酸水素ナトリウム水溶液および飽和炭硫ナトリ
ウム水溶液で洗浄し、無水硫酸ナトリウムで乾燥
後、溶媒を留去した。残留物を溶媒系クロロホル
ムメタノール−28%アンモニア水溶液(25:1:
0.1)を用いてシリカゲルカラムで精製し、19−
デカルボニル−22,4′−ジデオキシ−22−ジメチ
ルアミノ マイカミノシル タイロノライドを得
た。収量47.8mg(収率86%) 理化学的性状
[Table] (ii) Infrared absorption spectrum (KBr) WN (cm -1 ) Attribution 2970 −CH 3 2940 −CH 2 − 1710 −COO− 1680 >C=O 1590 −C=C−C=C− (iii ) Colorless needle crystals (recrystallized from acetone-n-hexane) (iv) Melting point 209-210℃ (v) Elemental analysis values (as C 30 H 50 NO 7 I) C(%) H(%) N(% ) I(%) Calculated value 54.30 7.59 2.11 19.12 Experimental value 54.58 7.51 2.31 19.25 (vi) [α] 25 D +97° (c1.0, CHCl 3 ) (vii) Ultraviolet absorption spectrum λ MeOH nax 282 nm (ε=
24000) Example 3 19-decarbonyl-22 obtained in Example 2,
4'-dideoxy-22-iodo mycaminosyl
63.6 mg of tylonolide was dissolved in 1.3 ml of anhydrous acetonitrile, and 0.24 ml of about 4M dimethylamine-acetonitrile solution was added. Seal tightly and heat at 80℃.
After heating for 30 minutes, 0.24 ml of the above solution was further added and heated for 30 minutes. After evaporating the solvent, the residue was dissolved in chloroform, and the chloroform layer was washed with a saturated aqueous sodium bicarbonate solution and a saturated aqueous sodium carbonate solution, dried over anhydrous sodium sulfate, and then the solvent was evaporated. The residue was dissolved in the solvent system chloroform methanol-28% ammonia aqueous solution (25:1:
Purify with a silica gel column using 19-
Decarbonyl-22,4'-dideoxy-22-dimethylamino mycaminosyl tylonolide was obtained. Yield 47.8mg (yield 86%) Physical and chemical properties

【表】【table】

【表】 (ii) 赤外線吸収スペクトル(KBr) WN(cm-1) 帰 属 2980 −CH3 2950 −CH2− 1730 −COO− 1680 >C=O 1595 −C=C−C=C− (iii) 無色無定形固体(アセトン−n−ヘキサンよ
り再結晶) (iv) 元素分析値(C32H56N2O7として) C(%) H(%) N(%) 計算値 66.18 9.72 4.82 実験値 65.94 9.43 4.60 (v) 〔α〕25 D+74゜(c1.0、CHCl3) (vi) 紫外線吸収スペクトルλMeOH nax283nm(ε=
22000) 実施例 4 19−デカルボニル−22,4′−ジデオキシ−22−
ヨード マイカミノシル タイロノライド78.5mg
を1.6mlの無水アセトニトリルに溶かし、ジイソ
ブチルアミン76mgを加え、80℃で2日間加温し
た。溶媒を留去した後、残留物を4mlのクロロホ
ルムに溶かし、クロロホルム層を2mlの飽和炭酸
水素ナトリウム水溶液および水で洗浄し、無水硫
酸ナトリウムで乾燥後、溶媒を留去した。残留物
を溶媒系クロロホルム−メタノール−28%アンモ
ニア水溶液(25:1:0.1)を用いてシリカゲル
カラムで精製し、19−デカルボニル−22,4′−ジ
デオキシ−22−ジイソブチルアミノ マイカミノ
シル タイロノライドを得た。収量59.5mg(収率
76%) 理化学的性状
[Table] (ii) Infrared absorption spectrum (KBr) WN (cm -1 ) Attribution 2980 −CH 3 2950 −CH 2 − 1730 −COO− 1680 >C=O 1595 −C=C−C=C− (iii ) Colorless amorphous solid (recrystallized from acetone-n-hexane) (iv) Elemental analysis value (as C 32 H 56 N 2 O 7 ) C (%) H (%) N (%) Calculated value 66.18 9.72 4.82 Experiment Value 65.94 9.43 4.60 (v) [α] 25 D +74° (c1.0, CHCl 3 ) (vi) Ultraviolet absorption spectrum λ MeOH nax 283 nm (ε=
22000) Example 4 19-decarbonyl-22,4'-dideoxy-22-
Iodo Mycaminocil Tyronolide 78.5mg
was dissolved in 1.6 ml of anhydrous acetonitrile, 76 mg of diisobutylamine was added, and the mixture was heated at 80°C for 2 days. After evaporating the solvent, the residue was dissolved in 4 ml of chloroform, and the chloroform layer was washed with 2 ml of saturated aqueous sodium bicarbonate solution and water, dried over anhydrous sodium sulfate, and then the solvent was evaporated. The residue was purified with a silica gel column using a solvent system of chloroform-methanol-28% ammonia aqueous solution (25:1:0.1) to obtain 19-decarbonyl-22,4'-dideoxy-22-diisobutylamino mycaminosyl tylonolide. . Yield 59.5 mg (yield
76%) Physical and chemical properties

【表】 (ii) 赤外線吸収スペクトル(KBr) WN(cm-1) 帰 属 2980 −CH3 2950 −CH2− 1730 −COO− 1680 >C=O 1595 −C=C−C=C− (iii) 元素分析値(C36H68N2O7として) C(%) H(%) N(%) 計算値 68.64 10.31 4.21 実験値 68.52 10.21 4.33 (iv) 〔α〕23 D+55゜(c1.0、CHCl3) (v) 紫外線吸収スペクトルλMeOH nax285nm(ε=
23000) 実施例 5 19−デカルボニル−22,4′−ジデオキシ−22−
ヨード マイカミノシル タイロノライド82.5mg
を1.7mlの無水アセトニトリルに溶かし、ピペリ
ジン52.3mgを加え、80℃で60分間加温した。溶媒
を留去した後、残留物を4mlのクロロホルムに溶
かし、2mlの飽和炭酸水素ナトリウム水溶液およ
び水で洗浄し、無水硫酸ナトリウムで乾燥後、溶
媒を留去した。残留物を溶媒系クロロホルム−メ
タノール−28%アンモニア水溶液(25:1:0.1)
を用いてシリカゲルカラムで精製し、19−デカル
ボニル−22,4′−ジデオキシ−22−ピペリジノ
マイカミノシル タイロノライドを得た。収量
70.7mg(収率92%) 理化学的性状
[Table] (ii) Infrared absorption spectrum (KBr) WN (cm -1 ) Attribution 2980 −CH 3 2950 −CH 2 − 1730 −COO− 1680 >C=O 1595 −C=C−C=C− (iii ) Elemental analysis value (as C 36 H 68 N 2 O 7 ) C (%) H (%) N (%) Calculated value 68.64 10.31 4.21 Experimental value 68.52 10.21 4.33 (iv) [α] 23 D +55° (c1. 0, CHCl 3 ) (v) Ultraviolet absorption spectrum λ MeOH nax 285 nm (ε=
23000) Example 5 19-decarbonyl-22,4'-dideoxy-22-
Iodo Mycaminocil Tyronolide 82.5mg
was dissolved in 1.7 ml of anhydrous acetonitrile, 52.3 mg of piperidine was added, and the mixture was heated at 80°C for 60 minutes. After evaporating the solvent, the residue was dissolved in 4 ml of chloroform, washed with 2 ml of saturated aqueous sodium bicarbonate solution and water, dried over anhydrous sodium sulfate, and then the solvent was evaporated. The residue was dissolved in a solvent system of chloroform-methanol-28% ammonia aqueous solution (25:1:0.1).
19-decarbonyl-22,4'-dideoxy-22-piperidino
I got mycaminocil tylonolide. yield
70.7mg (yield 92%) Physical and chemical properties

【表】 (ii) 赤外線吸収スペクトル(KBr) WN(cm-1) 帰 属 2980 −CH3 2950 −CH2− 1730 −COO− 1680 >C=O 1600 −C=C−C=C− (iii) 無色固体 (iv) 元素分析値(C35H60N2O7として) C(%) H(%) N(%) 計算値 67.71 9.74 4.51 実験値 67.65 9.62 4.66 (v) 〔α〕22 D+42゜(c1.0、CHCl3) (vi) 紫外線吸収スペクトルλMeOH nax284nm(ε=
25000) 実施例 6 19−デカルボニル−22,4′−ジデオキシ−22−
ヨード マイカミノシル タイロノライド84mgを
1.7mlの無水アセトニトリルに溶かし、N−メチ
ルシクロヘキシルアミン72mgを加え、80℃で4時
間加温した。溶媒を留去した後、残留物を5mlの
クロロホルムに溶かし、2mlの飽和炭酸水素ナト
リウム水溶液および水で洗浄し、無水硫酸ナトリ
ウムで乾燥後、溶媒を留去した。残留物を溶媒系
クロロホルム−メタノール−28%アンモニア水溶
液(25:1:0.1)を用いてシリカゲルカラムで
精製し、19−デカルボニル−22,4′−ジデオキシ
−22−(N−メチルシクロヘキシルアミノ)マイ
カミノシル タイロノライドを得た。 収量77.7mg(収率92%) 理化学的性状
[Table] (ii) Infrared absorption spectrum (KBr) WN (cm -1 ) Attribution 2980 −CH 3 2950 −CH 2 − 1730 −COO− 1680 >C=O 1600 −C=C−C=C− (iii ) Colorless solid (iv) Elemental analysis value (as C 35 H 60 N 2 O 7 ) C (%) H (%) N (%) Calculated value 67.71 9.74 4.51 Experimental value 67.65 9.62 4.66 (v) [α] 22 D +42゜(c1.0, CHCl 3 ) (vi) Ultraviolet absorption spectrum λ MeOH nax 284nm (ε=
25000) Example 6 19-decarbonyl-22,4'-dideoxy-22-
Iodine Mycaminocil Tyronolide 84mg
The mixture was dissolved in 1.7 ml of anhydrous acetonitrile, 72 mg of N-methylcyclohexylamine was added, and the mixture was heated at 80°C for 4 hours. After evaporating the solvent, the residue was dissolved in 5 ml of chloroform, washed with 2 ml of saturated aqueous sodium bicarbonate solution and water, dried over anhydrous sodium sulfate, and then the solvent was evaporated. The residue was purified with a silica gel column using a solvent system of chloroform-methanol-28% ammonia aqueous solution (25:1:0.1) to obtain 19-decarbonyl-22,4'-dideoxy-22-(N-methylcyclohexylamino). I got mycaminocil tylonolide. Yield 77.7mg (yield 92%) Physical and chemical properties

【表】【table】

【表】 (ii) 赤外線吸収スペクトル(KBr) WN(cm-1) 帰 属 2980 −CH3 2950 −CH2− 1730 −COO− 1680 >C=O 1600 −C=C−C=C− (iii) 無色固体 (iv) 元素分析値(C37H65N2O7として) C(%) H(%) N(%) 計算値 68.49 9.94 4.32 実験値 68.27 9.83 4.51 (v) 〔α〕22 D+77゜(c1.0、CHCl3) (vi) 紫外線吸収スペクトルλMeOH nax284nm(ε=
25000) 実施例 7 19−デカルボニル−22,4′−ジデオキシ−22−
ヨード マイカミノシル タイロノライド94.3mg
を2mlの無水アセトニトリルに溶かし、N−メチ
ルベンジルアミン86mgを加え、80℃で3時間加温
した。溶媒を留去した後、残留物を5mlのクロロ
ホルムに溶かし、2mlの飽和炭酸水素ナトリウム
水溶液および水で洗浄し、無水硫酸ナトリウムで
乾燥後、溶媒を留去した。残留物を溶媒系クロロ
ホルム−メタノール−28%アンモニア水溶液
(25:1:0.1)を用いてシリカゲルカラムで精製
し、19−デカルボニル−22,4′−ジデオキシ−22
−(N−メチルベンジルアミノ)マイカミノシル
タイロノライドを得た。収量81mg(収率87%) 理化学的性状
[Table] (ii) Infrared absorption spectrum (KBr) WN (cm -1 ) Attribution 2980 −CH 3 2950 −CH 2 − 1730 −COO− 1680 >C=O 1600 −C=C−C=C− (iii ) Colorless solid (iv) Elemental analysis value (as C 37 H 65 N 2 O 7 ) C (%) H (%) N (%) Calculated value 68.49 9.94 4.32 Experimental value 68.27 9.83 4.51 (v) [α] 22 D +77゜(c1.0, CHCl 3 ) (vi) Ultraviolet absorption spectrum λ MeOH nax 284nm (ε=
25000) Example 7 19-decarbonyl-22,4'-dideoxy-22-
Iodo Mycaminocil Tyronolide 94.3mg
was dissolved in 2 ml of anhydrous acetonitrile, 86 mg of N-methylbenzylamine was added, and the mixture was heated at 80°C for 3 hours. After evaporating the solvent, the residue was dissolved in 5 ml of chloroform, washed with 2 ml of saturated aqueous sodium bicarbonate solution and water, dried over anhydrous sodium sulfate, and then the solvent was evaporated. The residue was purified on a silica gel column using a solvent system of chloroform-methanol-28% ammonia aqueous solution (25:1:0.1) to give 19-decarbonyl-22,4'-dideoxy-22
-(N-methylbenzylamino)mycaminosyltylonolide was obtained. Yield 81mg (yield 87%) Physical and chemical properties

【表】 (ii) 赤外線吸収スペクトル(KBr) WN(cm-1) 帰 属 2980 −CH3 2950 −CH2− 1730 −COO− 1680 >C=O 1595 −C=C−C=C− (iii) 無色固体 (iv) 元素分析値(C38H60N2O7として) C(%) H(%) N(%) 計算値 69.48 9.21 4.26 実験値 69.20 9.11 4.32 (v) 〔α〕23 D+32゜(c1.0、CHCl3) (vi) 紫外線吸収スペクトルλMeOH nax284nm(ε=
26000)
[Table] (ii) Infrared absorption spectrum (KBr) WN (cm -1 ) Attribution 2980 −CH 3 2950 −CH 2 − 1730 −COO− 1680 >C=O 1595 −C=C−C=C− (iii ) Colorless solid (iv) Elemental analysis value (as C 38 H 60 N 2 O 7 ) C (%) H (%) N (%) Calculated value 69.48 9.21 4.26 Experimental value 69.20 9.11 4.32 (v) [α] 23 D +32゜(c1.0, CHCl 3 ) (vi) Ultraviolet absorption spectrum λ MeOH nax 284nm (ε=
26000)

Claims (1)

【特許請求の範囲】 1 一般式 〔式中、Rは水酸基、ハロゲン原子、または
【式】(式中、R1およびR2は同一また は異つて水素原子、低級アルキル基、アリール
基、アラルキル基または炭素数5〜10個のシクロ
アルキル基を表わす。またR1とR2は互いに結合
して炭素数3〜20個のアルキレン基を形成しても
よい。)で示される基を表わす。〕 で示される19−デカルボニル−4′−デオキシ マ
イカミノシル タイロノライド誘導体。
[Claims] 1. General formula [In the formula, R is a hydroxyl group, a halogen atom, or [Formula] (wherein, R 1 and R 2 are the same or different and are a hydrogen atom, a lower alkyl group, an aryl group, an aralkyl group, or a cyclocarbon group having 5 to 10 carbon atoms. represents an alkyl group. R 1 and R 2 may be bonded to each other to form an alkylene group having 3 to 20 carbon atoms. ] A 19-decarbonyl-4'-deoxy mycaminosyl tylonolide derivative represented by:
JP19262781A 1981-07-09 1981-11-30 19-decarbonyl-4'-deoxymycaminosyl tylonolide derivative Granted JPS5896096A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP19262781A JPS5896096A (en) 1981-11-30 1981-11-30 19-decarbonyl-4'-deoxymycaminosyl tylonolide derivative
AU85524/82A AU551142B2 (en) 1981-07-09 1982-07-01 Tylosin derivatives
US06/395,463 US4477443A (en) 1981-07-09 1982-07-06 Tylosin derivatives, their preparation and pharmaceutical compositions containing them
ES513827A ES513827A0 (en) 1981-07-09 1982-07-08 A METHOD OF PRODUCTION OF A TILOSIN DERIVATIVE.
EP84201085A EP0132895A1 (en) 1981-07-09 1982-07-09 Tylosin derivatives, their preparation and pharmaceutical compositions containing them
DE8282303622T DE3269164D1 (en) 1981-07-09 1982-07-09 Tylosin derivatives, their preparation and pharmaceutical compositions containing them
EP84201086A EP0134054A1 (en) 1981-07-09 1982-07-09 Tylosin derivatives, their preparation and pharmaceutical compositions containing them
EP82303622A EP0070170B1 (en) 1981-07-09 1982-07-09 Tylosin derivatives, their preparation and pharmaceutical compositions containing them
AT82303622T ATE18055T1 (en) 1981-07-09 1982-07-09 TYLOSINDIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES520906A ES520906A0 (en) 1981-11-30 1983-03-23 A METHOD FOR THE PREPARATION OF A THYLOSINE DERIVATIVE.
SU833622804A SU1209032A3 (en) 1981-11-30 1983-07-20 Method of producing tylosine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19262781A JPS5896096A (en) 1981-11-30 1981-11-30 19-decarbonyl-4'-deoxymycaminosyl tylonolide derivative

Publications (2)

Publication Number Publication Date
JPS5896096A JPS5896096A (en) 1983-06-07
JPS6316394B2 true JPS6316394B2 (en) 1988-04-08

Family

ID=16294389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19262781A Granted JPS5896096A (en) 1981-07-09 1981-11-30 19-decarbonyl-4'-deoxymycaminosyl tylonolide derivative

Country Status (3)

Country Link
JP (1) JPS5896096A (en)
ES (1) ES520906A0 (en)
SU (1) SU1209032A3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5933298A (en) * 1982-08-19 1984-02-23 Microbial Chem Res Found Tylosin derivative
ES2374950T3 (en) * 2006-07-28 2012-02-23 Intervet International B.V. MACROLIDOS SYNTHESIS PROCEDURE.

Also Published As

Publication number Publication date
SU1209032A3 (en) 1986-01-30
JPS5896096A (en) 1983-06-07
ES8405025A1 (en) 1984-05-16
ES520906A0 (en) 1984-05-16

Similar Documents

Publication Publication Date Title
KR920002142B1 (en) Method for selective metilacion of erythromycine a derivatives
JPS62155289A (en) Production of 1, 6-dichloro-1, 6-dideoxy-beta-d- fructofranosyl-4-chloro-4-deoxy-alpha-galactop-yranoside
JP2546659B2 (en) Method for producing podophyllotoxin type compound
JPS6123200B2 (en)
EP0070170A1 (en) Tylosin derivatives, their preparation and pharmaceutical compositions containing them
JPH03120292A (en) Benzopyranone-beta-d-thioxyrocide and method of its preparation
JPS6316394B2 (en)
JPS6360031B2 (en)
JPH0742304B2 (en) Novel anthracycline derivative and method for producing the same
EP0202111B1 (en) Antibacterial mycaminosyl tylonolide derivatives and their production
JPS632275B2 (en)
JPH04300879A (en) L-talopyranoside derivative and method of manufacturing same
JPS6316393B2 (en)
JPS6242919B2 (en)
JPS631952B2 (en)
JPH058200B2 (en)
AU4158499A (en) Morphine-6-glucuronide synthesis
IE43088B1 (en) Cardenolide glycosides and methods of making the same
US7214791B2 (en) Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
JPS632276B2 (en)
SU406347A1 (en)
JPS6152839B2 (en)
JPS637198B2 (en)
JPH039918B2 (en)
JP3051213B2 (en) Maltooligosaccharide derivatives, their synthetic intermediates and their production